BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma

BACKGROUNDS: Immunotherapy is effective in a subset of head and neck squamous cell carcinoma (HNSCC). However, the unfavorable response rate and inadequate biomarkers for stratifying patients have primarily limited its clinical application. Considering transcriptional factors (TFs) play essential ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xue, Xu, Xun, Wang, Lixuan, Zhang, Siyuan, Chen, Yingyao, Yang, Rongchun, Chen, Xijuan, Cheng, Bin, Xia, Juan, Ren, Xianyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911441/
https://www.ncbi.nlm.nih.gov/pubmed/36776328
http://dx.doi.org/10.3389/fonc.2023.1021262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911441/
https://www.ncbi.nlm.nih.gov/pubmed/36776328
http://dx.doi.org/10.3389/fonc.2023.1021262

Ejemplares similares